Facebook Pixel
Laboratory Considerations for Clinical Trials

Hybrid assays: an interview with Barry Jones and Adriane Spytko

Laboratory Considerations for Clinical Trials
Laboratory Considerations for Clinical Trials
Becoming bilingual in bioanalysis

In this podcast Barry Jones (Director, LC–MS Biologics and Biomarkers at Q² Solutions) and Adriane Spytko (Manager, LC–MS Biologics at Q² Solutions; both NY, USA) discuss hybrid assays using both LBA and LC−MS techniques. They share their thoughts on bottom-up LC−MS methods and the concern about detecting analyte that is not intact as well as future projects that bridge LC−MS and LBA.

Laboratory Considerations for Clinical Trials
Ei soiteta